Molecular detection of metallo-β-lactamase acquired genes, blaIMP and blaVIM in Carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR
| dc.contributor.author | Mudathir Abdallah Adam | |
| dc.contributor.author | Hadeel I Ismail | |
| dc.contributor.author | Wafa I Elhag | |
| dc.date.accessioned | 2018-04-02T19:59:56Z | |
| dc.date.available | 2018-04-02T19:59:56Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background: Emergence of Metallo-β-lactamase (MBL) is of great concern in the clinical settings worldwide. The death rate associated with MBL producers is ranging from 18% to 67%. The main purpose of this study is to determine the prevalence of metallo-β lactamase genes among different Gram-negative clinical isolates. | en_US |
| dc.identifier.issn | 1858-6228 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/11657 | |
| dc.publisher | جامعة النيلين - مجلة الدراسات العليا | en_US |
| dc.title | Molecular detection of metallo-β-lactamase acquired genes, blaIMP and blaVIM in Carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR | en_US |